Literature DB >> 340135

Basic experiments with clotrimazole administered orally.

M Seo, H iida, Y Miura.   

Abstract

A series of experiments was carried out with the antimycotic agent clotrimazole to establish MICs against a number of different yeasts and to estimate its blood levels following oral administration. Marked differences were noted between the MIC against A and B serotypes of Candida albicans in its yeast-like cell form, that against Type B being nearly 10-times higher than against Type A. Against the mycelial form, however, the MIC was much lower and there was little difference between the levels for the two serotypes. Clotrimazole administered in oral tablet form appeared to be poorly absorbed, little being transferred to the blood. Urinary levels were low and large amounts of the drug were detected in the faeces. Serum levels were below MIC levels in all cases examined. Blood levels 3-times as great as those after the same dosage in tablet form were produced when clotrimazole was given in oil solution and even with 250 mg, effective blood levels were achieved and maintained.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 340135     DOI: 10.1185/03007997709110160

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

1.  Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro.

Authors:  Hui Liu; Yufeng Li; Kevin P Raisch
Journal:  Anticancer Drugs       Date:  2010-10       Impact factor: 2.248

2.  Clotrimazole troches can alter everolimus pharmacokinetics in post-transplant patients: A case report.

Authors:  Takaya Uno; Kyoichi Wada; Sachi Matsuda; Megumi Ikura; Hiromi Takenaka; Nobue Terakawa; Akira Oita; Satoshi Yokoyama; Atsushi Kawase; Kouichi Hosomi; Mitsutaka Takada
Journal:  Br J Clin Pharmacol       Date:  2019-06-26       Impact factor: 4.335

3.  Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.

Authors:  T Tiffert; H Ginsburg; M Krugliak; B C Elford; V L Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.

Authors:  C Brugnara; L de Franceschi; S L Alper
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.

Authors:  C Brugnara; B Gee; C C Armsby; S Kurth; M Sakamoto; N Rifai; S L Alper; O S Platt
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

6.  Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients.

Authors:  Emily Wings; Michael Spinner; Jamie Eckardt
Journal:  Transpl Infect Dis       Date:  2022-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.